미용 의료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 시술 유형별(침습적 시술, 비침습적 시술), 지역별, 경쟁별(2020-2030년)

Aesthetic Medicine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Procedure Type (Invasive procedures, Non-invasive procedure ), By Region, & Competition, 2020-2030F

US $ 4,500 ￦ 6,401,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,824,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,380,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

미용 의료 세계 시장은 2024년에는 1,332억 5,000만 달러로 2030년에는 2,671억 4,000만 달러에 달할 것으로 예상되며, 연평균 12.25%의 성장률을 기록할 것으로 예측됩니다.

이 시장은 인구통계학적 변화, 기술 발전, 아름다움에 대한 문화적 인식의 변화, 퍼스널케어에 대한 소비 지출 증가 등을 배경으로 크게 성장하고 있습니다. 이 산업에는 외모를 개선하고, 피부를 젊어지게 하고, 노화로 인한 결점을 줄이기 위한 다양한 침습적 및 비침습적 치료법이 존재합니다. 보톡스(R)나 디스포트(R)와 같은 신경조절제, 피부 필러, 레이저 치료, 비수술적 윤곽 성형, 모발 재생 등이 대표적입니다. 이러한 치료는 이제 가끔씩의 미용적 개입이 아닌 지속적인 자기 관리의 일환으로 채택되고 있습니다. 초음파 유도하 윤곽 성형 및 프락셔널 레이저와 같은 새로운 기술로 인해 미용 기기 분야도 견인력을 얻고 있습니다. 예방 의료로의 전환은 미용 의료를 사치스러운 선택에서 웰빙과 자기 이미지에 대한 지속적인 투자로 재정의하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	1,332억 5,000만 달러
시장 규모 : 2030년	2,671억 4,000만 달러
CAGR : 2025-2030년	12.25%
급성장 부문	비침습적 시술
최대 시장	북미

시장 촉진요인

최소침습 수술에 대한 수요 증가

주요 시장 과제

안전에 대한 우려

주요 시장 동향

커스터마이징 및 개인화

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 미용 의료 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 시술 종류별(침습적 시술, 비침습적 시술)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 미용 의료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 미용 의료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 미용 의료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 미용 의료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 미용 의료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병

제13장 세계의 미용 의료 시장 : SWOT 분석

제14장 경쟁 구도

• Evolus, Inc.
• Cynosure LLC.
• Revance Therapeutics, Inc.
• Galderma S.A.
• Alma Lasers Inc.
• AbbVie Inc.
• Solta Medical Inc.
• Lumenis Inc.
• Syneron Inc.
• Bausch Health Companies, Inc..

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The Global Aesthetic Medicine Market was valued at USD 133.25 billion in 2024 and is projected to reach USD 267.14 billion by 2030, growing at a CAGR of 12.25%. This market is experiencing significant expansion driven by demographic changes, advancements in technology, evolving cultural perceptions of beauty, and increasing consumer spending on personal care. The industry encompasses a wide array of invasive and non-invasive treatments designed to enhance appearance, rejuvenate the skin, and reduce age-related imperfections. Key offerings include neuromodulators like Botox(R) and Dysport(R), dermal fillers, laser procedures, non-surgical body contouring, and hair restoration. These treatments are now being adopted as part of ongoing self-care routines rather than occasional cosmetic interventions. The aesthetic devices segment is also gaining traction, with new technologies such as ultrasound-guided contouring and fractional lasers offering improved outcomes. A shift toward preventive care is redefining aesthetic medicine from a luxury choice to a recurring investment in wellness and self-image.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 133.25 Billion
Market Size 2030	USD 267.14 Billion
CAGR 2025-2030	12.25%
Fastest Growing Segment	Non-invasive Procedure
Largest Market	North America

Key Market Drivers

Growing Demand for Minimally Invasive Procedures

The rising demand for minimally invasive aesthetic procedures is a key driver of the global aesthetic medicine market. In 2023 alone, about 25.4 million minimally invasive cosmetic procedures were performed globally, indicating a shift in consumer preference toward treatments with minimal downtime and reduced risk. These procedures-such as Botox injections, dermal fillers, laser resurfacing, and microneedling-offer aesthetic improvements with greater convenience and less recovery time than traditional surgeries. Products like Botox, Dysport, Xeomin, and Jeuveau continue to lead the market, with nearly 9.5 million procedures recorded, marking a 9% year-over-year increase. This trend is particularly popular among working professionals and younger individuals who favor discreet, time-efficient treatments. The market is also expanding demographically, with more men and first-time users opting for non-surgical enhancements. As a result, clinics are seeing increased patient traffic and retention, making these offerings a central component of aesthetic service portfolios.

Key Market Challenges

Safety Concerns

Despite their popularity, aesthetic procedures-especially minimally invasive ones-are not without risks, which remain a major concern for both consumers and practitioners. Adverse events such as infections, allergic reactions, scarring, and tissue necrosis can deter potential patients. Negative media coverage of unsuccessful treatments further fuels public apprehension and can damage industry reputation. These safety issues also invite greater regulatory scrutiny, which can complicate clinical operations and restrict access to certain procedures. Practitioners must also navigate the legal risks of malpractice claims, which can drive up insurance costs and lead to reduced service offerings. Educating patients thoroughly about the potential risks and setting realistic expectations are essential but time-intensive tasks that may slow the decision-making process, thereby affecting market momentum.

Key Market Trends

Customization and Personalization

A major trend shaping the aesthetic medicine market is the growing emphasis on personalized and customized treatments. Patients are increasingly seeking procedures tailored to their unique facial structures, aesthetic goals, and skin types-whether for wrinkle reduction, contouring, or pigmentation correction. Personalized approaches lead to higher satisfaction, improved outcomes, and stronger practitioner-patient relationships, fostering loyalty and repeat visits. Technological advancements such as AI-driven diagnostics, 3D imaging, and digital simulation tools allow providers to design highly individualized treatment plans. This inclusive approach accommodates diverse patient demographics across ethnicities, genders, and age groups. Additionally, personalized aesthetic regimens often involve multi-step, combination treatments that deliver comprehensive results, further enhancing the appeal of custom solutions in today's beauty market.

Key Market Players

• Evolus, Inc.
• Cynosure LLC.
• Revance Therapeutics, Inc.
• Galderma S.A.
• Alma Lasers Inc.
• AbbVie Inc.
• Solta Medical Inc.
• Lumenis Inc.
• Syneron Inc.
• Bausch Health Companies, Inc.

Report Scope:

In this report, the Global Aesthetic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Aesthetic Medicine Market, By Procedure Type:

• Invasive procedures
• Non-invasive procedure

Aesthetic Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aesthetic Medicine Market.

Available Customizations:

Global Aesthetic Medicine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Aesthetic Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure Type (Invasive procedures, Non-invasive procedure)
    • 5.2.1.1. By Invasive procedures (Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, Others)
    • 5.2.1.2. By Non-invasive procedures (Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Aesthetic Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Aesthetic Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure Type
  • 6.3.2. Canada Aesthetic Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure Type
  • 6.3.3. Mexico Aesthetic Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure Type

7. Europe Aesthetic Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Aesthetic Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure Type
  • 7.3.2. United Kingdom Aesthetic Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure Type
  • 7.3.3. Italy Aesthetic Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure Type
  • 7.3.4. France Aesthetic Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure Type
  • 7.3.5. Spain Aesthetic Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure Type

8. Asia-Pacific Aesthetic Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure Type
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Aesthetic Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure Type
  • 8.3.2. India Aesthetic Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure Type
  • 8.3.3. Japan Aesthetic Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure Type
  • 8.3.4. South Korea Aesthetic Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure Type
  • 8.3.5. Australia Aesthetic Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure Type

9. South America Aesthetic Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Aesthetic Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure Type
  • 9.3.2. Argentina Aesthetic Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure Type
  • 9.3.3. Colombia Aesthetic Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure Type

10. Middle East and Africa Aesthetic Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Aesthetic Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure Type
  • 10.3.2. Saudi Arabia Aesthetic Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure Type
  • 10.3.3. UAE Aesthetic Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Aesthetic Medicine Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Evolus, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cynosure LLC.
• 14.3. Revance Therapeutics, Inc.
• 14.4. Galderma S.A.
• 14.5. Alma Lasers Inc.
• 14.6. AbbVie Inc.
• 14.7. Solta Medical Inc.
• 14.8. Lumenis Inc.
• 14.9. Syneron Inc.
• 14.10.Bausch Health Companies, Inc..

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료